Product Pathways - Ca / cAMP / Lipid Signaling
TPA (12-O-Tetradecanoylphorbol-13-Acetate) #4174
- Molecular Formula:
- Molecular Weight:
- 616.84 g/mol
Directions for Use
TPA is supplied as a 1 mg powder. Store at -20C. Before use, dissolve powder in 1 ml DMSO to yield a 1.6 mM stock solution. For working concentration of 200 μM, add 125 μl stock solution to 875 μl DMSO. Treat cells with 200 nM TPA for 20-30 minutes.
Western blot analysis of extracts from serum-starved 293 cells, untreated (lane 1), stimulated with TPA treatment (lanes 2 & 3), and treated with CIP and λ phosphatase (lane 3), using Phospho-PKC (pan) (βII Ser660) Antibody #9371 or PKCα Antibody #2056.
TPA (12-O-tetradecanoylphorbol-13-acetate)/ PMA (phorbol-12-myristate-13-acetate) is soluble in DMSO and ethanol. DMSO solutions can be stored at -20C, in the absence of light, for at least six months. A 200 nM TPA treatment is standard to induce signaling.
TPA (12-O-tetradecanoylphorbol-13-acetate) / PMA (phorbol-12-myristate-13-acetate) is the most commonly used phorbol ester. It binds and activates protein kinase C, causing a wide range of effects in cells and tissues (1,2). TPA has been demonstrated to be a potent tumor promoter in mouse skin (3). Conversely, it has been shown to be an effective cancer therapeutic agent in myelocytic leukemia patients, and has been indicated as a potential colorectal cancer therapeutic (4-5). TPA has also been shown to increase white blood cell and neutrophil counts in solid tumor cancer patients (6).
- Rebois, R.V. and Patel, J. (1985) J Biol Chem 260, 8026-31.
- Blumberg, P.M. (1980) Crit Rev Toxicol 8, 153-97.
- Fürstenberger, G. et al. (1981) Proc Natl Acad Sci U S A 78, 7722-6.
- Han, Z.T. et al. (1998) Proc Natl Acad Sci U S A 95, 5357-61.
- Lee, H.W. et al. (2002) J Biol Chem 277, 32624-31.
- Han, Z.T. et al. (1998) Proc Natl Acad Sci U S A 95, 5362-5.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.